On June 3, Anne Carol Goldberg, MD, FACP, FAHA, FNLA received the W. Virgil Brown Distinguished Achievement Award from the National Lipid Association (NLA).
The award is the highest honor given out by the NLA and acknowledges outstanding contributions in the diagnosis and treatment of lipid disorders.
Dr. Anne Carol Goldberg is an endocrinologist and lipid specialist. She received her medical degree from the University of Maryland and completed an internal medicine residency at Michael Reese Hospital, Chicago, Illinois, and an endocrinology fellowship at Washington University School of Medicine, St. Louis, Missouri. Where she is currently a Professor of Medicine in the Division of Endocrinology, Metabolism and Lipid Research.
Dr. Goldberg’s research interests include therapies for hyperlipidemia and the treatment of familial hypercholesterolemia. She has conducted clinical trials involving most classes of lipid-modifying drugs. She treats adults and children with dyslipidemia, including familial hypercholesterolemia, and has a lipoprotein apheresis program. Awards she has received include the National Forum for Heart Disease and Stroke Prevention Public Policy Award, the Foundation of the National Lipid Association Clinician/Educator Award, and the Washington University School of Medicine Distinguished Clinician Award.
She is a Past President of the NLA and Immediate Past President of the Foundation of the NLA. Goldberg chaired the NLA Expert Panel on Familial Hypercholesterolemia and was a member of the ACC/AHA Blood Cholesterol Expert Panel for the 2013 ACC/AHA Cholesterol Guidelines and of the task force for the Endocrine Society Clinical Practice Guideline on Evaluation and Treatment of Hypertriglyceridemia. She is currently the Chief Science Officer of the NLA.